Clinical Trials Browser

Terminated × Has results × sargramostim × Clear all

NCT03927222 2024-04-08

I-ATTAC

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

NCT00006478 2023-09-18

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

Phase 2 Terminated

19 enrolled 4 charts

Lymphoma, Lymphoma, Follicular

NCT02978222 2022-12-15

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Phase 2 Terminated

120 enrolled 12 charts

Ovarian Neoplasms

NCT00415857 2018-08-21

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Phase 2 Terminated

5 enrolled 3 charts

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01174082 2018-06-01

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Phase 2 Terminated

2 enrolled 7 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00014560 2018-05-03

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase 1 Terminated

3 enrolled 3 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00477087 2017-11-29

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

Phase 2 Terminated

10 enrolled 10 charts

Prostatic Neoplasms

NCT00673179 2014-09-10

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Phase NA Terminated

7 enrolled 3 charts

Osteosarcoma

NCT01542684 2014-04-30

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

Phase 2 Terminated

8 enrolled 5 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

NCT00308087 2013-12-27

PREMIER

Phase 2 Terminated

75 enrolled 12 charts

Lymphoma, Follicular

NCT00208975 2012-06-28

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Phase 2 Terminated

15 enrolled 5 charts

Lymphoma

NCT00048893 2012-04-13

Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer

Phase 1/2 Terminated

37 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00505921 2011-11-16

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

Phase 2 Terminated

27 enrolled 5 charts

Lymphoma, Lymphoma, T-Cell